Hydroxyapatite is a naturally occurring mineral form of
calcium apatite, with the formula Ca5(PO4)3OH. It is the major inorganic
component of human hard tissue such as bones and teeth. Hydroxyapatite can be
used as substitutes or extenders in bone grafting procedures and is an
important material for hard tissue engineering applications due to its ability
to bond chemically with bone. Hydroxyapatite delivers superior osteogenesis,
osteoconduction and is well-tolerated by the body without invoking any
undesirable immune reactions.
The global Hydroxyapatite Market is estimated to be valued
at US$ 2761.23 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024 to 2031, as highlighted
in a new report published by Coherent Market Insights.
Market key trends:
Growing demand from orthopedic and dental applications is one of the key
trends driving the growth of the hydroxyapatite market. Hydroxyapatite has
ability to fuse naturally with human bones and hence is widely used as bone
graft substitutes for spinal fusion surgeries, trauma fixation and bone defect
fillings. It is also used in dental applications for repair and reconstruction
of damaged bones in jaw, teeth and gums. According to the U.S. National Library
of Medicine, over 500,000 bone grafting procedures are carried out each year in
United States to repair bone fractures that fail to heal naturally or for
spinal fusions. Growing prevalence of orthopedic diseases and rising awareness
regarding tissue regeneration is expected to drive the demand for
hydroxyapatite over the forecast period.
Segment Analysis
The global Hydroxyapatite market is segmented by product into nano-sized,
micro-sized and greater than micrometer. The nano-sized hydroxyapatite segment dominates
the market and is expected to witness high growth over the forecast period.
Nano-sized hydroxyapatite possesses superior biocompatibility and bioactivity
properties making it a popular choice for biomedical applications like bone
graft substitutes and coatings for dental and orthopedic implants.
Key Takeaways
Regional analysis:
North America region currently dominates the hydroxyapatite
market and is expected to grow at a CAGR of 7.4% during the forecast period.
High prevalence of orthopedic disorders coupled with advanced healthcare
infrastructure and growing biomedical industry are major growth drivers in the
region. Asia Pacific region is projected to be the fastest growing market owing
to large patient pool, increasing healthcare spending and rising medical
tourism.
Key players:
The global hydroxyapatite market is consolidated in nature
with few major players operating globally. Key players operating in the
hydroxyapatite market are West Pharmaceutical Services Inc., Berry Global Inc.,
Sartorius AG, Corning Inc., Gerresheimer AG, SCHOTT AG, Stevanato Group,
AptarGroup Inc., SGD Pharma, Ompi - Stevanato Group, DWK Life Sciences, Nipro
Corporation, Nolato AB, Terumo Corporation, Qosina Corp. Among them, West
Pharmaceutical Services Inc., Berry Global Inc. and Sartorius AG collectively
account for over 30% of the global market share. These players are focused on
new product launches, partnerships and capacity expansions to strengthen their
market position.
Get more insights on this topic: https://www.ukwebwire.com/hydroxyapatite-market-industry-insightstrendshydroxyapatite-market/
Explore
more information on this topic, Please visit: https://masstamilan.tv/cannabis-beverages-the-emerging-trend-in-cannabis-industry/
Comments
Post a Comment